If we use EV/EBIT ratio, PGH should be at $1.86 if it's trading on par with ORA valuation.. so definitely lots of upside..
- Forums
- ASX - By Stock
- PGH
- Ann: 2023 Half-Year Results Presentation
Ann: 2023 Half-Year Results Presentation, page-19
-
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGH (ASX) to my watchlist
|
|||||
Last
78.5¢ |
Change
-0.005(0.63%) |
Mkt cap ! $271.9M |
Open | High | Low | Value | Volume |
76.5¢ | 78.5¢ | 76.5¢ | $268 | 348 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1095 | 76.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
78.5¢ | 522 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 1095 | 0.765 |
1 | 50000 | 0.760 |
1 | 1329 | 0.750 |
2 | 1900 | 0.730 |
1 | 7187 | 0.705 |
Price($) | Vol. | No. |
---|---|---|
0.785 | 522 | 3 |
0.790 | 2 | 1 |
0.795 | 3247 | 2 |
0.800 | 41968 | 4 |
0.840 | 2000 | 1 |
Last trade - 11.14am 16/07/2024 (20 minute delay) ? |
Featured News
PGH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online